any ideas on how one can incorporate this into a cycle or if this is anything worth looking into..is this a substitue for taking GH ?? hola back please and thanks !
2ez2brich
**************************************************
if ghrp2 makes children taller thats real hgh at work ! .. below taken
off the net ...do not be fooled by imitations and claims !its a
synthetic drug,not naturally occuring so suppllement companies can not touch
it ,not offered elswhere,DISCLAIMER:HGH does not make you big unless you
are a children or over 40 but used by pros on thier contest prep as it
help with fat lose ..
Treatment effects of GHRP-2 in children with short stature.
> Pihoker C; Badger TM; Reynolds GA; Bowers CY
> Department of Pediatrics, University of
> Washington, Seattle 98105,
> USA.
> J Endocrinol, 1997 Oct, 155:1, 79-86
>
> Abstract
Growth hormone-releasing peptide (GHRP)-2 is a
synthetic six amino acid peptide that is a
potent GH secretagogue. Although it shares no
structural homology with GH-releasing
hormone, in clinical studies its actions on the
pituitary release of GH are similar. It is effective
when administered orally and intranasally. For
children with GH deficiency, such noninvasive
treatments are most desirable and in need of
development. Fifteen children with short stature
participated in this study. All of the children had a height < 2 S.D.
below mean for age, poor
height velocity, delayed bone age, and low
serum concentrations of IGF-1. These children
had been tested with standard GH secretagogues,
e.g. arginine,insulin, and L-dopa. Fifty
percent of the children were GH deficient, the
remainder had idiopathic short stature. The
children received testing with GHRH and GHRP-2
as an acute i.v.bolus of 1 microgram/kg;
all children in this study demonstrated a GH
response > 20micrograms/l. Each child in this
study also demonstrated a GH response > 10micrograms/l in response to
intranasal GHRP-2, in the dose range of ¡°5-20
micrograms/kg¡±. The children were administered
intranasal GHRP-2, 5-15 micrograms/kg, twice a
day for 3 months,then three times a day. Fifteen children
participated in the study for 6 months; six of the children have
participated for 18-24 months. Height velocity, serum IGF-1,IGF-binding
protein 3(IGFBP-3)and GH-binding protein (GHBP) concentrations, and GH
responses to
GHRP-2 by i.v. bolus and intranasal spray were examined during
treatment. Height velocity increased from 3.7 +/-0.2 cm/year to 6.1 +/- 0.3
cm/year at 6 months,6.0 +/- 0.4 cm/year at 18-24 months.There were no
significant changes in IGF-1 or IGF-PB3 concentrations, or in acute GH
responses to i.v. or intranasal GHRP-2. GHBP concentrations rose
significantly, from 439+/- 63 pmol/l to 688 +/- 48 pmol/l. In this study GHRP-2
administration was well tolerated, and produced a modest but significant
increase in growth velocity.
ghrpt2 CERT. OF ANALYSIS avaiable,dose is min 5mg/day ,place under
tongue till fully disolve ,more ghrp2 = more hgh ...
2ez2brich
**************************************************
if ghrp2 makes children taller thats real hgh at work ! .. below taken
off the net ...do not be fooled by imitations and claims !its a
synthetic drug,not naturally occuring so suppllement companies can not touch
it ,not offered elswhere,DISCLAIMER:HGH does not make you big unless you
are a children or over 40 but used by pros on thier contest prep as it
help with fat lose ..
Treatment effects of GHRP-2 in children with short stature.
> Pihoker C; Badger TM; Reynolds GA; Bowers CY
> Department of Pediatrics, University of
> Washington, Seattle 98105,
> USA.
> J Endocrinol, 1997 Oct, 155:1, 79-86
>
> Abstract
Growth hormone-releasing peptide (GHRP)-2 is a
synthetic six amino acid peptide that is a
potent GH secretagogue. Although it shares no
structural homology with GH-releasing
hormone, in clinical studies its actions on the
pituitary release of GH are similar. It is effective
when administered orally and intranasally. For
children with GH deficiency, such noninvasive
treatments are most desirable and in need of
development. Fifteen children with short stature
participated in this study. All of the children had a height < 2 S.D.
below mean for age, poor
height velocity, delayed bone age, and low
serum concentrations of IGF-1. These children
had been tested with standard GH secretagogues,
e.g. arginine,insulin, and L-dopa. Fifty
percent of the children were GH deficient, the
remainder had idiopathic short stature. The
children received testing with GHRH and GHRP-2
as an acute i.v.bolus of 1 microgram/kg;
all children in this study demonstrated a GH
response > 20micrograms/l. Each child in this
study also demonstrated a GH response > 10micrograms/l in response to
intranasal GHRP-2, in the dose range of ¡°5-20
micrograms/kg¡±. The children were administered
intranasal GHRP-2, 5-15 micrograms/kg, twice a
day for 3 months,then three times a day. Fifteen children
participated in the study for 6 months; six of the children have
participated for 18-24 months. Height velocity, serum IGF-1,IGF-binding
protein 3(IGFBP-3)and GH-binding protein (GHBP) concentrations, and GH
responses to
GHRP-2 by i.v. bolus and intranasal spray were examined during
treatment. Height velocity increased from 3.7 +/-0.2 cm/year to 6.1 +/- 0.3
cm/year at 6 months,6.0 +/- 0.4 cm/year at 18-24 months.There were no
significant changes in IGF-1 or IGF-PB3 concentrations, or in acute GH
responses to i.v. or intranasal GHRP-2. GHBP concentrations rose
significantly, from 439+/- 63 pmol/l to 688 +/- 48 pmol/l. In this study GHRP-2
administration was well tolerated, and produced a modest but significant
increase in growth velocity.
ghrpt2 CERT. OF ANALYSIS avaiable,dose is min 5mg/day ,place under
tongue till fully disolve ,more ghrp2 = more hgh ...